76-90 of 188
Nutritional Strategies for Managing IgA Nephropathy
Clinician's RoundtableNutritional Strategies for Managing IgA Nephropathy
Jennifer Moore, MS, RDN, CSR, LDN
Charles Turck, PharmD, BCPS, BCCCP
Rare Kidney Disease: A Parent and Caregiver’s Perspective
Clinician's RoundtableRare Kidney Disease: A Parent and Caregiver’s Perspective
Gates B. Colbert, MD
Kelly Helm
Decoding Proteinuria: A Window into Kidney Health in IgAN
Clinician's RoundtableDecoding Proteinuria: A Window into Kidney Health in IgAN
Unlocking Early Detection of IgA Nephropathy: The Critical Role of Timely Diagnosis
On the Frontlines of IgA NephropathyUnlocking Early Detection of IgA Nephropathy: The Critical Role of Timely Diagnosis
Suneel Udani, MD
Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
On the Frontlines of IgA NephropathyDiagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
Gates B. Colbert, MD
Agnes B. Fogo, MD
Advances in IgAN: New Frontiers in Biomarkers and Treatment
On the Frontlines of IgA NephropathyAdvances in IgAN: New Frontiers in Biomarkers and Treatment
Gates B. Colbert, MD
Edward Filippone, MD
- advertisement
Reducing Proteinuria and Function Loss in IgAN: A Recap of the NefigArd Trial
On the Frontlines of IgA NephropathyReducing Proteinuria and Function Loss in IgAN: A Recap of the NefigArd Trial
Jonathan Barratt, MD, PhD
Innovations in IgAN Care: Examining the Evolving Treatment Landscape
On the Frontlines of IgA NephropathyInnovations in IgAN Care: Examining the Evolving Treatment Landscape
Jonathan Barratt, MD, PhD
The Future of IgA Nephropathy: Why Biomarkers Matter
On the Frontlines of IgA NephropathyThe Future of IgA Nephropathy: Why Biomarkers Matter
Jonathan Barratt, MD, PhD
Investigating the Potential Link Between Chronic Tonsillitis and IgA Nephropathy
Clinician's RoundtableInvestigating the Potential Link Between Chronic Tonsillitis and IgA Nephropathy
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Project Oncology®Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Jody Takemoto, PhD, MEd
David Braun
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Project Oncology®The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Jody Takemoto, PhD, MEd
David Braun, MD, PhD
- advertisement
Real-World Data on Treatment Choices for mccRCC
Project Oncology®Real-World Data on Treatment Choices for mccRCC
Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation
Project Oncology®Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation
Diabetes and CKD: Strategies for Diagnosis and Treatment
Diabetes DiscourseDiabetes and CKD: Strategies for Diagnosis and Treatment
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Ian de Boer, MD
